← back to search

Martha Quezado

National Institutes of Health · US
Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Neuroblastoma Research and Treatments, and Pituitary Gland Disorders and Treatments.
h-index
55
citations
16,770
works
285
NIH funding
primary concept
Medicine
email

Recent publications

Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors
Neuro-Oncology Advances 2025cited by 2position: middledoi
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1
Neuro-Oncology 2024cited by 23position: middledoi
Papillary tumor of the pineal region: analysis of DNA methylation profiles and clinical outcomes in 76 cases
Acta Neuropathologica Communications 2024cited by 10position: middledoi
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency
Neuro-Oncology Advances 2023cited by 15position: middledoi
SARS-CoV-2 infection and persistence in the human body and brain at autopsy
Nature 2022cited by 887position: middledoi
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation
Cell 2022cited by 505position: middledoi
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13
Acta Neuropathologica 2022cited by 56position: middledoi
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1
Acta Neuropathologica 2022cited by 52position: middledoi
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions
Acta Neuropathologica 2022cited by 20position: middledoi
Recurrent ACVR1 mutations in posterior fossa ependymoma
Acta Neuropathologica 2022cited by 18position: middledoi
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
Acta Neuropathologica 2021cited by 55position: middledoi
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Clinical Cancer Research 2019cited by 659position: middledoi
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview
Human Pathology 2017cited by 423position: middledoi
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Nature Medicine 2015cited by 707position: middledoi
X-linked acrogigantism syndrome: clinical profile and therapeutic responses
Endocrine Related Cancer 2015cited by 185position: middledoi
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
New England Journal of Medicine 2014cited by 884position: middledoi
Multifocal dysembryoplastic neuroepithelial tumours associated with refractory epilepsy
Epileptic Disorders 2014cited by 16position: middledoi
Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor
Cancer Discovery 2013cited by 353position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Arie Perry · City College of San Francisco3 papers (2017–2024)Mark R. Gilbert · BC Centre for Disease Control3 papers (2022–2023)Calixto‐Hope G. Lucas · Johns Hopkins University2 papers (2022–2024)Mark Raffeld · National Institutes of Health2 papers (2022–2022)Markku Miettinen · National Institute of General Medical Sciences2 papers (2017–2024)Terri S. Armstrong · National Institutes of Health2 papers (2022–2022)David Viskochil · University of Utah2 papers (2017–2024)Zied Abdullaev · National Institutes of Health2 papers (2022–2022)Antonios Papanicolau‐Sengos · Roswell Park Comprehensive Cancer Center2 papers (2022–2022)Alexander J. Lazar · Disco (Germany)2 papers (2017–2024)Courtney Ketchum · Center for Cancer Research2 papers (2022–2022)Kenneth Aldape · National Institute of Mental Health2 papers (2022–2022)Caterina Giannini · Wake Forest University2 papers (2022–2022)Pavalan Selvam · Center for Cancer Research2 papers (2022–2022)Drew Pratt · University of Pittsburgh2 papers (2022–2022)David A. Solomon · Saveetha University2 papers (2022–2022)Anat Stemmer‐Rachamimov · Massachusetts General Hospital2 papers (2017–2024)Andrew I. Yang · New York University1 papers (2014–2014)Guangyang Yu · Fudan University1 papers (2023–2023)Bao Tran · National Cancer Institute1 papers (2023–2023)